Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.79M Sell
7,925
-1,487
-16% -$530K 0.1% 196
2025
Q4
$3.08M Sell
9,412
-482
-5% -$153K 0.11% 188
2025
Q3
$2.79M Buy
9,894
+3,303
+50% +$958K 0.1% 196
2025
Q2
$1.84M Sell
6,591
-8,348
-56% -$2.36M 0.07% 232
2025
Q1
$4.65M Buy
14,939
+3,491
+30% +$1.03M 0.2% 108
2024
Q4
$2.98M Sell
11,448
-64
-0.6% -$19K 0.22% 114
2024
Q3
$3.71M Buy
11,512
+563
+5% +$184K 0.28% 87
2024
Q2
$3.42M Buy
10,949
+31
+0.3% +$9.11K 0.28% 87
2024
Q1
$3.1M Sell
10,918
-501
-4% -$147K 0.27% 89
2023
Q4
$3.36M Buy
11,419
+326
+3% +$88.8K 0.32% 70
2023
Q3
$2.93M Buy
11,093
+4,205
+61% +$1.05M 0.32% 76
2023
Q2
$1.8M Sell
6,888
-2,136
-24% -$496K 0.2% 159
2023
Q1
$2.18M Buy
9,024
+311
+4% +$76.3K 0.23% 123
2022
Q4
$2.29M Sell
8,713
-89
-1% -$23.9K 0.27% 106
2022
Q3
$2.38M Sell
8,802
-19,295
-69% -$4.68M 0.29% 97
2022
Q2
$6.95M Buy
28,097
+2,374
+9% +$582K 0.83% 14
2022
Q1
$6.22M Buy
25,723
+20,038
+352% +$4.6M 0.72% 20
2021
Q4
$1.29M Buy
+5,685
New +$1.2M 0.17% 191

Other funds holding AMGN

Ascent Group's AMGN Position: Q1 2026 in Review

Ascent Group reduced its Amgen (AMGN) stake by 16% in Q1 2026, selling an estimated $530K and leaving 7,925 shares worth $2.79M. The position accounts for 0.1% of the portfolio, ranked #196.

Ascent Group first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.95M in Q2 2022. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ascent Group held 7,925 shares of Amgen worth $2.79M as of Q1 2026.
  • Ascent Group sold 1,487 Amgen shares in Q1 2026, an estimated $530K.
  • Amgen made up 0.1% of Ascent Group's portfolio in Q1 2026, its #196 holding.
  • Ascent Group first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Ascent Group's Amgen position peaked at $6.95M in Q2 2022.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.